ISMP To Work With New Expert Committee To Improve Patient Safety

The Institute for Safe Medication Practices (ISMP) is collaborating with a number of patient advocacy groups to accelerate improvements to patient safety in the U.S. healthcare system, according to a recent announcement.

Two new collaborative efforts are being pursued, with ISMP indicating in a press release issued on last week that it is joining the National Steering Committee for Patient Safety formed in May, and the Joint Commission’s National Patient Safety Collaborative.

The steering committee seeks to create a national action plan that will guide nationwide patient safety efforts. It includes healthcare experts, patient advocates, and regulators. The committee plans to identify action priorities, and coordinate strategies for addressing key areas of patient safety concern.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

The committee is organized and led by The Institute for Healthcare Improvement (IHI), and the Agency for Healthcare Research and Quality (AHRQ).

“For decades, experts have called for increased coordination to improve patient safety, but such a strategy has not been fully instituted,” IHI Chief Clinical and Safety Officer, and co-chair of the committee, Dr. Tejal Gandhi said in a press release (PDF). “There is still so much work to be done in patient safety, in part because we’ve reached the limits of what a project-by-project approach can achieve. Instead of declaring ‘mission accomplished,’ we need to take steps to advance total systems safety — safety that is reliably and uniformly applied wherever care is provided.”

The National Patient Safety Collaborative is an effort by the Joint Commission which seeks to coordinate the efforts of patient safety groups nationwide.

The Joint Commission is a not-for-profit organization that accredits and certifies health care groups and programs in the U.S. While it is independent and not a government organization, it’s certifications are widely recognized in the U.S. healthcare industry.

A patient survey published by IHI in 2017 found that one-fifth of all Americans are affected by medical errors.

In addition, 31 percent of patients said they knew someone whose care they were personally involved with who experienced a medical error as well. But the study found that less than half of those who felt there had been a medical mistake then brought it to the attention of healthcare professionals at the facility where it occurred.

The study also found that the majority of medical errors occurred in outpatient settings, and that medical misdiagnosis and failures in communication between healthcare professionals and patients are the most common causes. Nearly 60% of those who say they had an experience with a medical error cited misdiagnosis, delayed diagnosis, or a failure to diagnose as the problem.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Depo-Provera Meningioma Brain Tumors Risks May Have Been Ignored by Pfizer for Decades
Depo-Provera Meningioma Brain Tumors Risks May Have Been Ignored by Pfizer for Decades (Posted 2 days ago)

After decades of medical research and reported Depo-Provera side effects, Pfizer should have known that its birth control shot increases the risks of meningioma brain tumors, yet failed to warn women or the medical community.

Philadelphia Roundup Lawsuit Ends in Defense Verdict for Monsanto
Philadelphia Roundup Lawsuit Ends in Defense Verdict for Monsanto (Posted 2 days ago)

Bayer and Monsanto prevailed in a Roundup lawsuit that went to trial in Philadelphia this week, after a jury found that exposure to the herbicide did not cause a man to develop non-Hodgkin's lymphoma.